DEBBIE PIERCE: Open Payments
NPI 1235744608 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 81 payments from 12 companies in 2025. Trend: 2023 $956 · 2024 $1,459 · 2025 $1,552
Food & beverage: $1,441Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $266 |
| Otsuka America Pharmaceutical, Inc. | 11 | $222 |
| Teva Pharmaceuticals USA, Inc. | 5 | $193 |
| ABBVIE INC. | 10 | $183 |
| E.R. Squibb & Sons, L.L.C. | 9 | $167 |
| Alkermes, Inc. | 10 | $165 |
| Lundbeck LLC | 8 | $137 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
Products named: REXULTI, Auvelity, VRAYLAR, COBENFY, FANAPT, AUSTEDO XR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
